Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACSF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | MRPL57 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | TCEA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | PEA15 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | CCDC18 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | S100A10 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | PDXP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ACADM | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PTPRM | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |